Objective: To evaluate post-traumatic growth experienced by medical doctors who served coronavirus disease-2019 patients. Method: The cross-sectional study was conducted from December 1, 2021, to February 28, 2022, at the Civil Hospital, Karachi, and comprised medical doctors of either gender aged >22 years who directly provided care for at least one month to coronavirus disease-2019 patients. Other than demographic and professional profile of the subjects, data was collected using the Post-Traumatic Growth Inventory, with total score 60 indicating a positive post-traumatic growth. Data was analysed using SPSS 22. Results: Of the 166 subjects approached, 150(90.3%) finished the study. There were 90(60%) females, 88(58.7%) were aged 25-35 years, 55(36.7%) were married, 107(71.3%) were postgraduate trainees, 79(52.7%) had 1-3 family members in the vulnerable groups, and 43(28.7%) had received any sort of psychological training. The mean post-traumatic growth score was 64.81±20.27 and 87(58%) doctors scored 60. The odds of experiencing post-traumatic growth for doctors with the number of vulnerable family members were significant (p 0.05). Doctors who had received psychological training before providing care to coronavirus disease-2019 patients showed higher odds of experiencing post-traumatic growth (p 0.05). Conclusion: Coronavirus disease-2019 resulted in substantial positive psychological growth for frontline doctors. Psychological training showed a significant role in post-traumatic growth. Key Words: Post-traumatic growth, Psychological COVID-19, Healthcare provider, Pakistan.
INTRODUCTION Several risk factors have been associated with inflammatory bowel diseases (IBD), including genetic, environmental, gut microbiota and immune dysregulation. Psychiatric disorders have been linked to IBD. However, the question of whether psychiatric conditions affect the severity of patients with IBD remains unanswered. We aimed to investigate the relationship between mood disorders and IBD outcomes. METHODS This is a retrospective longitudinal study of patients admitted with a primary diagnosis of IBD. Data was retrieved from the Nationwide Inpatient Sample (NIS) databases of the years 2016 to 2019 using ICD-10-CM codes for IBD. Multivariate logistic regression analysis was applied to estimate the effect of mood disorders on the outcomes of IBD (mortality, complications and hospital utilization), while adjusting for patient and hospital confounders. A T-Test and Chi Square test were performed to compare baseline characteristics in patients admitted for IBD with and without a secondary diagnosis of mood disorder (table 1). We used Stata® Version 17.0 Software (Statacorp, Texas, USA) for analysis. The p-value was set at p < 0.05. RESULTS A total of 374745 adults with a primary diagnosis of IBD were identified; less than one fifth (21%) had a documented mood disorder. A significantly higher proportion of females (66%, p-value=0.000) and Whites (81%, p-value=0.000) were noted in the mood disorder group. Having a mood disorder was associated with no statistically significant change in mortality (Odds ratio (OR) = 0.86, p = 0.461), anemia (OR = 0.99; p = 0.891), gastrointestinal bleed (OR = 0.99; p = 0.910), inflammatory polyps (OR = 0.79; p = 0.452), toxic megacolon (OR = 0.79; p = 0.664), colorectal cancer (OR = 0.70; p = 0.133), primary sclerosing cholangitis (OR = 1.34; p = 0.228), and pyoderma gangrenosum (OR = 1.01; p = 0.945) (figure 1). A statistically but non clinically significant reduction in the risk of intestinal abscess (OR= 0.81; p = 0.024), stenosis (OR= 0.68; p = 0.000), and fistula (OR= 0.84; p =0.012), was noted in patients with mood disorder. However, an increased hospital utilization was noted in patients with mood disorder (length of stay: 0.59 days, p-value = 0.000; total healthcare cost: 3372 US Dollars, p-value = 0.000). DISCUSSION IBD patients demonstrate a higher prevalence of mood disorders when compared to the general population, especially in females and Whites. Our study showed that the presence of mood disorder concurrently with IBD does not significantly affect the outcomes of IBD in terms of mortality, or morbidity. A multidisciplinary approach of patients with IBD including diagnosis and management of the underlying psychiatric disorders could help optimize the hospital utilization of patients with IBD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.